Trinity Biotech Cash Flow Statement (2009-2024) | TRIB

Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Operating Activities
Net Income 3.00M3.98M3.83M3.61M3.73M47.06M-0.59M4.92M5.17M5.36M5.36M5.24M5.43M5.38M5.32M4.52M4.38M5.50M5.30M4.64M4.87M4.91M4.50M4.62M3.13M12.94M3.27M-0.98M2.37M-0.22M-43.26M2.75M3.37M2.96M1.18M3.30M3.24M2.55M3.36M2.81M8.23M2.78M1.78M3.08M1.76M10.69M9.56M4.39M0.53M1.85M-3.51M-13.37M-10.18M-9.99M-10.80M-6.33M-18.61M-6.72M-5.51M-3.18M-6.89M-4.83M-16.18M
Depreciation and Depletion 577.000.15M47.000.48M0.45M351.00305.00173.000.00M164.00-65.00260.000.32M
Cash from Discontinued Operations 4.33M0.68M2.27M-4.66M0.24M3.35M
Gains from Investment Securities -72.000.40M13.00-0.00M-0.01M0.40M-0.07M-0.23M
Asset Writedowns and Impairment -6.07M-0.88M-0.52M2.29M-3.03M0.01M-0.29M-0.45M-0.96M
Cash from Restructuring 3.73M
Non-cash Items 4.08M4.93M4.70M5.28M4.91M4.42M5.26M4.67M4.77M5.17M5.03M5.00M5.12M5.61M5.59M5.97M5.18M4.89M5.82M3.88M4.99M5.92M6.07M5.05M6.30M4.13M3.85M5.57M2.50M5.28M5.16M3.29M2.27M3.74M3.67M3.09M3.26M3.20M3.44M3.17M3.21M3.10M3.18M2.70M2.47M1.31M9.72M4.68M4.06M-0.00M2.23M4.90M-0.02M995.00-0.40M3.06M-0.18M2.60M7.01M
Change in Working Capital -1.77M-0.71M-0.58M-0.46M0.22M1.47M-0.33M1.61M0.98M-0.88M-0.34M-0.93M-1.82M-0.77M-0.69M-0.08M-2.55M-2.79M-2.29M-0.92M-4.21M-4.31M-0.54M3.60M-4.32M-2.91M-0.17M0.23M-0.63M-3.23M0.39M1.32M-2.21M-0.37M0.31M1.73M-2.68M-1.47M-0.51M-2.94M-0.53M-1.58M1.63M-0.32M-1.40M1.47M-2.55M10.16M1.83M-3.15M-1.78M-1.88M-1.28M
Change in Taxes 655.00-29.00
Cash from Operations 2.31M4.22M4.12M4.82M5.13M5.88M4.93M6.28M5.75M4.29M4.69M4.06M3.29M4.84M4.89M5.89M2.63M2.09M3.53M2.96M0.78M1.61M5.53M8.64M1.98M1.22M3.69M5.81M1.88M2.05M5.56M4.62M0.06M3.37M3.98M4.82M0.58M1.74M2.93M0.23M2.68M1.53M4.82M2.38M1.07M2.78M7.17M14.84M5.89M1.30M0.45M3.91M-1.30M2.29M-0.01M-7.13M0.31M-0.00M-3.92M3.58M
Depreciation, Depletion & Amortization
Amortization of Goodwill 0.01M0.88M519.003.03M0.29M0.96M
Amortizatization of Intangibles 240.000.23M214.000.27M0.21M251.00179.0056.000.46M527.00218.00338.000.11M
Amortization 0.31M0.30M1.96M7.35M18.64M24.76M
Depreciation & Amortization (CF) 577.000.15M47.000.48M0.45M351.00305.00173.000.00M164.00-65.00260.000.32M
Investing Activities
Capital Expenditures -2.50M-1.89M-1.60M-2.39M-2.32M-1.11M-1.51M2.17M-389.00-0.57M-143.00-0.32M-0.47M-0.13M-0.25M-0.16M
Change in Intangibles -0.00M-1.91M-0.00M-1.00M-0.66M-0.49M-0.64M-2.58M
Acquisitions 1.09M0.31M
Divestments -0.27M
Cash from Investing Activities -0.00M-2.48M-0.00M-1.32M-1.14M-0.89M-0.89M-2.74M
Financing Activities
Other financing activities 0.00M975.00812.00114.00
Cash from Financing Activities -3.59M-2.37M-1.84M-2.43M-1.77M1.80M
Dividend Payments
Dividends Paid - Common -2.15M-3.22M-4.37M-5.03M-5.10M
Additional items
Exchange Rate Effect 95.000.17M-153.00-0.18M0.03M0.01M-0.16M-0.09M
Change in Cash -1.73M-3.02M-0.71M-7.98M-2.41M2.42M
Free Cash Flow 4.81M6.11M5.72M7.21M7.46M6.99M6.44M4.11M5.75M4.29M4.69M4.06M3.29M4.84M4.89M5.89M2.63M2.09M3.53M2.96M0.78M1.61M5.53M8.64M1.98M1.22M3.69M5.81M1.88M2.05M5.56M4.62M0.06M3.37M3.98M4.82M0.58M1.74M2.93M0.23M2.68M1.53M4.82M2.38M1.07M2.78M7.17M14.84M5.89M1.31M0.45M4.48M-1.30M143.000.32M2.76M-0.01M-7.13M0.13M0.56M-0.00M-3.92M3.74M
Net Cash Flow 2.31M4.22M4.12M4.82M5.13M5.88M4.93M6.28M5.75M4.29M4.69M4.06M3.29M4.84M4.89M5.89M2.63M2.09M3.53M2.96M0.78M1.61M5.53M8.64M1.98M1.22M3.69M5.81M1.88M2.05M5.56M4.62M0.06M3.37M3.98M4.82M0.58M1.74M2.93M0.23M2.68M1.53M4.82M2.38M1.07M2.78M7.17M14.84M5.89M1.30M0.45M-2.15M-1.30M-0.00M-3.70M-0.70M-0.01M-7.13M-3.32M-2.35M-0.00M-3.92M2.65M